| Financial Year |
March 31 2023 |
| Monetary Funds |
810,124,747.77 |
| Held-for-trading Financial Assets |
122,386,377.65 |
| Notes Receivable |
122,896,501.26 |
| Accounts Receivable |
1,526,359,468.91 |
| Advances to Suppliers |
148,356,312.99 |
| Other Receivables |
129,459,750.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,350,400,426.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,595,640.20 |
| Total Current Assets |
4,523,906,823.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
246,416,440.08 |
| Investment Properties |
228,730,910.25 |
| Fixed Assetes |
350,185,366.75 |
| Under-construction Projects |
6,003,178.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
105,448,724.07 |
| R&D expenses |
-- |
| Goodwill |
56,530,918.70 |
| Long-Term Deferred and Prepaid Expenses |
10,691,001.84 |
| Deferred Income Tax Assets |
57,029,720.35 |
| Other Non-Current Assets |
34,632,210.37 |
| Sub-Total of Non-Current Assets |
1,133,190,965.32 |
| Total Assets |
5,657,097,788.83 |
| Short-Term Loans |
459,707,592.86 |
| Trading Financial liabilities |
-- |
| Notes Payable |
616,850,532.62 |
| Accounts Payable |
1,163,928,825.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
45,719,123.60 |
| Taxes Payable |
15,802,857.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
101,583,788.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,456,063.23 |
| Other Current Liabilities |
113,920,741.11 |
| Sub-Total of Current Liabilities |
3,296,441,131.04 |
| Long-term Loans |
175,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
32,309,272.29 |
| Deferred Income Tax Liabilities |
343,563.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
454,396,577.06 |
| Total Liabilities |
3,750,837,708.10 |
| Paid-In Capital(Or Share Stock) |
780,242,234.00 |
| Capital Surplus |
3,294,821,129.03 |
| Surplus Reserve |
33,244,430.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,327,697,953.04 |
| Minority Stockholder's Interest |
130,139,855.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,776,120,225.45 |
| Owner's Equity（Stockholder's Equity） |
1,906,260,080.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,657,097,788.83 |
